News
Fong replaced Brad Lerman as Medtronic’s GC, who retired in 2022 before being lured out of retirement to become CLO at ...
Medtronic is bringing on a medical device industry veteran for its new top lawyer as it prepares for a major organizational ...
Ivan Fong, 63, was one of the highest-proifile GCs to sign an amicus brief supporting Perkins Coie's legal challenge of ...
We came across a bullish thesis on Becton, Dickinson and Company on Disruptive Analytics’ Substack by Magnus Ofstad. In this ...
StockStory.org on MSN8d
BD’s Q1 Earnings Call: Our Top 5 Analyst QuestionsBecton, Dickinson and Company’s first quarter results were met with a sharp negative market reaction, reflecting concerns ...
Review the current Becton Dickinson & Co (BDX:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if BDX is the best investment for you.
To enable awareness and knowledge-sharing around best practices of atherothrombectomy in the treatment of vascular diseases a ...
Becton Dickinson said production of its recently approved rapid test for the coronavirus strain Covid-19 will ramp up to 12 million tests per month by the end of February 2021.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results